Mode
Text Size
Log in / Sign up

Age Not Independent Predictor of Outcomes After Thrombectomy in Stroke Patients ≥70 YearsWhy Being 85 Shouldn't Cost Grandma Her Shot at Stroke Recovery

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that age may not independently predict thrombectomy outcomes when stroke severity is accounted for.

A retrospective single-center cohort study examined predictors of functional outcomes after endovascular thrombectomy in 94 patients aged ≥70 years with acute ischemic stroke. The cohort included 44 septuagenarians (70-79 years) and 50 octo/nonagenarians (≥80 years). The primary outcome was a modified Rankin Scale score of 0-2 at 3 months follow-up. No comparator group was reported.

In unadjusted analysis, good functional outcomes occurred in 27.3% of septuagenarians compared to 8.0% of octo/nonagenarians (p=0.0274). However, in multivariable logistic regression adjusting for other factors, age was not an independent predictor of poor outcomes (adjusted odds ratio 2.40, 95% CI 0.65-10.08; p=0.1991). Bayesian logistic regression found higher NIHSS scores were associated with poorer outcomes (OR 0.90, 95% credible interval 0.81-0.98), while prior intravenous thrombolysis predicted better outcomes (OR 6.59, 95% credible interval 1.16-23.09).

Safety and tolerability data were not reported. Key limitations include the retrospective design, single-center setting, and small sample size of 94 patients. Funding and conflicts of interest were not reported.

For practice, this study suggests that in patients aged ≥70 years selected for thrombectomy, age alone may not independently predict functional outcomes when accounting for other clinical factors like stroke severity. However, the observational nature and limited sample preclude definitive conclusions about age-based selection criteria.

The phone call no family is ready for

It's 3 a.m. Your 82-year-old mother has had a stroke. The emergency doctor calls with a choice.

They can do a procedure called thrombectomy — threading a tiny catheter into her brain and pulling the clot out. But the doctor mentions her age. She wonders aloud if it's worth the risk.

You're stuck. Is she too old? Would it just cause more harm?

New research suggests the answer may be simpler — and more hopeful — than doctors have long assumed.

What thrombectomy actually does

Most strokes happen when a blood clot blocks an artery in the brain. Brain cells start dying within minutes.

Thrombectomy is an emergency procedure that uses a thin tube, threaded through a blood vessel in the groin or wrist, to physically grab the clot and pull it out. It can restore blood flow and save brain tissue — sometimes with dramatic recovery.

It's one of the biggest advances in stroke care of the last 20 years.

The old thinking, and why it needs updating

For years, older patients were often passed over for thrombectomy. The fear was that elderly brains couldn't bounce back, and the procedure itself carried too many risks.

But here's the twist. Studies have started to show that a lot of older adults do recover well. The question became — which ones?

Is it really about age? Or is it about something else that travels with age?

The stroke-versus-age puzzle

Think of it like this. Two 85-year-olds walk into the ER with strokes.

One has a small clot, caught early, with little prior brain damage on her scan.

The other has a bigger clot, already a few hours old, with a brain showing years of slow wear-and-tear from high blood pressure.

They're the same age. Their odds of recovery are nothing alike.

Researchers wanted to know — if you compare patients fairly, does age itself really drive the outcome? Or is age just tagging along with other, more important factors?

The study in plain terms

A team followed 94 stroke patients aged 70 or older who got thrombectomy at a single hospital.

They split the group in two. Septuagenarians (ages 70 to 79) went in one bucket. Octogenarians and nonagenarians (80 and older) went in the other.

Three months after the stroke, they checked how well each person was doing using a simple scale from 0 (no problems) to 6 (died). Scores of 0 to 2 count as "good outcome" — meaning the person is independent or close to it.

On the surface, older patients did worse. Only 8 percent of patients 80 and older hit that "good outcome" mark, versus 27 percent of those in their 70s.

That sounds like age matters a lot.

But here's where the story shifts.

When researchers did the math to adjust for other factors — things like how severe the stroke was and how much brain damage already existed — age itself stopped predicting outcome.

In plain English, age was guilty by association. The real culprits were:

  • How bad the stroke was at arrival
  • How much "old wear" the brain already showed
  • How much brain tissue had already died by the time treatment started

Patients who had received the clot-busting drug before thrombectomy did better. Patients with higher stroke-severity scores did worse.

Age, standing alone? Not a reliable predictor.

Doctors make tough triage calls every day. If age has been quietly biasing those calls, older patients may have been missing out on a treatment that could help them.

This study says that decision should rest on the stroke — not the birthday.

Where this fits

This finding echoes what other recent research has hinted. Older adults as a group have more strokes and more complications, but when matched on stroke severity, many recover as well as younger patients.

The takeaway is that "elderly" is not a monolith. An active, independent 88-year-old is not the same as a frail, bedbound 70-year-old.

If you're advocating for an older loved one in the ER, don't let age alone rule out thrombectomy.

Ask the stroke team to walk you through the specifics. What's the stroke severity score? How much brain tissue is already damaged? How much time has passed since symptoms started?

These are the numbers that actually shape the decision. Advanced age by itself should not close the door.

And if you're planning ahead for yourself or a parent, discuss wishes for emergency stroke care now — not during a crisis. Most older adults want aggressive treatment when there's a real chance of recovery.

The honest limits

This was a single hospital. Only 94 patients. The researchers looked back at old records rather than following a planned trial.

Results from one center may not perfectly match outcomes at another. Hospitals differ in how quickly they treat stroke, which equipment they use, and which patients they select.

Still, the pattern fits with growing evidence from larger studies around the world.

Bigger, multi-hospital studies will firm up the answer. Researchers are also working on better tools to predict which older patients benefit most — things like imaging scores and frailty assessments.

In the meantime, the message for families and doctors is becoming clearer. When a stroke hits, judge the stroke, not the age.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
IntroductionThe clinical factor impact on outcomes after endovascular thrombectomy (EVT) in patients aged ≥70 years remains incompletely understood. We aimed to identify predictors of good outcomes after EVT in patients aged ≥70 years, defined as a modified Rankin Scale (mRS) score of 0–2.MethodsThis retrospective, single-center cohort study included 94 patients aged ≥70 years with acute ischemic stroke who underwent EVT. Participants were stratified into septuagenarians (n = 44) and octo/nonagenarians (n = 50). We evaluated post-EVT modified thrombolysis in cerebral infarction reperfusion grade, symptomatic intracerebral hemorrhage, and mRS score at 3 months follow-up as outcomes. Both multivariable (LR) and Bayesian logistic regression (BLR) and sensitivity analyses were conducted to derive adjusted odds ratio (aOR) and assess the probabilistic associations between clinical variables and outcomes.ResultsAt presentation, the median ischemic core was higher in octo/nonagenarians compared to septuagenarians (20 mL vs. 4 mL, p = 0.0464); median Alberta Stroke Program Early CT Score was lower (7 vs. 8, p = 0.0112). Higher Fazekas grades of leukoaraiosis were more frequent in octo/nonagenarians (p = 0.0297) than in septuagenarians. Good mRS outcomes were achieved by 27.3% of septuagenarians vs. 8.0% of octo/nonagenarians (p = 0.0274). In the multivariable LR, age was not an independent predictor of poor outcomes (aOR 2.40; 95% CI, 0.65–10.08; p = 0.1991). BLR identified higher National Institutes of Health Stroke Scale scores [odds ratio (OR) 0.90; 95% credible interval, 0.81–0.98] associated with poorer outcomes, whereas prior intravenous thrombolysis (OR 6.59; 1.16–23.09) predicted better outcomes. BLR did not show probabilistic certainty of age as a predictor of functional outcomes. Including infarct core in the model did not impact sensitivity analysis results.ConclusionAge was not independently associated with functional outcomes. Age-related differences in outcomes may be mediated by initial stroke characteristics rather than age.Clinical trial registrationClinicalTrials.gov, identifier NCT06953427.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.